1. Home
  2. AMPH vs BVS Comparison

AMPH vs BVS Comparison

Compare AMPH & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

SELL

Current Price

$25.94

Market Cap

1.0B

Sector

Health Care

ML Signal

SELL

Logo Bioventus Inc.

BVS

Bioventus Inc.

SELL

Current Price

$13.44

Market Cap

892.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AMPH
BVS
Founded
1996
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
892.4M
IPO Year
2005
2016

Fundamental Metrics

Financial Performance
Metric
AMPH
BVS
Price
$25.94
$13.44
Analyst Decision
Hold
Strong Buy
Analyst Count
7
5
Target Price
★ $22.50
$17.60
AVG Volume (30 Days)
★ 486.8K
404.4K
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 163.46
EPS
★ 0.81
0.52
Revenue
★ $719,887,000.00
$568,087,000.00
Revenue This Year
$3.87
$6.46
Revenue Next Year
$4.90
$6.74
P/E Ratio
$32.16
★ $26.21
Revenue Growth
N/A
★ N/A
52 Week Low
$16.65
$6.47
52 Week High
$29.52
$15.89

Technical Indicators

Market Signals
Indicator
AMPH
BVS
Relative Strength Index (RSI) 58.55 50.85
Support Level $25.23 $13.44
Resistance Level $29.40 $14.33
Average True Range (ATR) 0.91 0.47
MACD -0.10 0.01
Stochastic Oscillator 35.20 57.07

Price Performance

Historical Comparison
AMPH
BVS

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: